Seaview Investment Managers LLC Cuts Stake in HCA Healthcare, Inc. $HCA

Seaview Investment Managers LLC reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 13.2% during the 4th quarter, Holdings Channel.com reports. The firm owned 17,160 shares of the company’s stock after selling 2,606 shares during the period. HCA Healthcare accounts for about 3.0% of Seaview Investment Managers LLC’s portfolio, making the stock its 20th biggest position. Seaview Investment Managers LLC’s holdings in HCA Healthcare were worth $8,012,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of HCA. Harbour Investments Inc. grew its holdings in shares of HCA Healthcare by 13.1% during the fourth quarter. Harbour Investments Inc. now owns 380 shares of the company’s stock valued at $177,000 after buying an additional 44 shares during the last quarter. Allstate Corp grew its holdings in shares of HCA Healthcare by 81.8% during the fourth quarter. Allstate Corp now owns 12,424 shares of the company’s stock valued at $5,800,000 after buying an additional 5,591 shares during the last quarter. Fisher Asset Management LLC boosted its holdings in HCA Healthcare by 19.8% in the fourth quarter. Fisher Asset Management LLC now owns 1,360 shares of the company’s stock valued at $635,000 after purchasing an additional 225 shares during the last quarter. CYBER HORNET ETFs LLC boosted its holdings in HCA Healthcare by 4.7% in the fourth quarter. CYBER HORNET ETFs LLC now owns 531 shares of the company’s stock valued at $248,000 after purchasing an additional 24 shares during the last quarter. Finally, Clearstead Advisors LLC boosted its holdings in HCA Healthcare by 24.9% in the fourth quarter. Clearstead Advisors LLC now owns 1,073 shares of the company’s stock valued at $501,000 after purchasing an additional 214 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Trading Up 0.1%

HCA stock opened at $394.40 on Tuesday. The company has a market cap of $87.49 billion, a price-to-earnings ratio of 13.56, a PEG ratio of 1.25 and a beta of 1.18. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The firm has a 50-day moving average of $462.41 and a two-hundred day moving average of $483.23.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same period in the previous year, the firm posted $6.45 EPS. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Robert W. Baird reduced their price target on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Weiss Ratings downgraded shares of HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, May 18th. Jefferies Financial Group restated a “buy” rating and set a $525.00 price target on shares of HCA Healthcare in a research report on Friday, April 24th. Finally, Sanford C. Bernstein reduced their price target on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating for the company in a research report on Tuesday, April 28th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $515.77.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.